EUVIMEDEUVIMED entdecken
Crossref

Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithm

Christina Koenig, Cole P McGrath, Hanna F Roenfanz, Yuwei Shen, Marguerite L Monogue iD, David P Nicolau iD, Joseph L Kuti

Journal of Antimicrobial Chemotherapy · 01.08.2025 · 80 (8) · 2269-2279

DOI: 10.1093/jac/dkaf199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 27.06.2025. Verfasst von Christina Koenig und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Anti-Infective Research & Development, Hartford Hospital, Hartford, CT, USA. Hauptthemen laut MEDLINE: Algorithms, Continuous Renal Replacement Therapy, Anti-Bacterial Agents, Anti-Infective Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: US Food and Drug Administration, FDA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Few ex vivo continuous renal replacement therapy (CRRT) studies to determine transmembrane clearance (CLTM) have resulted in direct dosage recommendations for patients on CRRT. Comparing the results of these studies with pharmacokinetic assessments in critically ill patients on CRRT could validate their findings and help guide dosage selection.

Methods

CLTM was combined with non-renal clearance and used for Monte Carlo simulations to derive an ex vivo dosing algorithm for cefepime, meropenem, levofloxacin and micafungin regimens at varying CRRT effluent rates (ERs). Criteria for optimal dose selection depended on overall exposure (AUC24 h) and drug-specific pharmacodynamic efficacy targets. Plasma collected from CRRT patients, as part of standard care, were analysed and concentrations fitted to pharmacokinetic models. Bayesian estimates were then used to re-simulate selected dosing regimens. Predictive performance of the ex vivo dosing algorithm was assessed by median prediction error (MPE) for AUC24 h at a given dose.

Results

Ex vivo algorithms demonstrated good performance with MPEs within ±30% for cefepime and meropenem, while for levofloxacin, larger MPE (−22 to −52%) deviations were observed across different ER ranges. For cefepime, meropenem and levofloxacin, optimal attainment of their respective pharmacodynamic target was predicted with the ex vivo algorithm derived dosing regimens. Micafungin displayed no ex vivo CLTM, and standard dosing resulted in AUC24 h values comparable with non-CRRT patients.

Conclusions

These data support the use of ex vivo CRRT models to develop optimal dosing regimens for a variety of antimicrobials, which could then be validated in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsContinuous Renal Replacement TherapyAnti-Bacterial AgentsAnti-Infective AgentsHumansMiddle AgedAgedMaleMeropenemFemaleMonte Carlo MethodMicafunginCritical IllnessBayes TheoremPlasmaCefepimeAdult

Substanzen

MeropenemAnti-Bacterial AgentsMicafunginAnti-Infective AgentsCefepime

Autor:innen und Institutionen

  • Center for Anti-Infective Research & Development, Hartford Hospital, Hartford, CT, USA.
  • Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Division of Infectious Diseases, Hartford Hospital, Hartford, CT, USA.

ORCID-Profile: Marguerite L Monogue, David P Nicolau

Förderung

  • US Food and Drug Administration
  • FDA

Zitieren

APA

Koenig, C., McGrath, C. P., Roenfanz, H. F., Shen, Y., Monogue, M. L., Nicolau, D. P., & Kuti, J. L. (2025). Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithm. Journal of Antimicrobial Chemotherapy, 80(8), 2269-2279. https://doi.org/10.1093/jac/dkaf199

Vancouver

Koenig C, McGrath CP, Roenfanz HF, Shen Y, Monogue ML, Nicolau DP, et al. Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithm. Journal of Antimicrobial Chemotherapy. 2025;80(8):2269-2279. doi:10.1093/jac/dkaf199

BibTeX
@article{Koenig2025,
  author = {Koenig, Christina and McGrath, Cole P and Roenfanz, Hanna F and Shen, Yuwei and Monogue, Marguerite L and Nicolau, David P and Kuti, Joseph L},
  title = {Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithm},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {8},
  pages = {2269--2279},
  doi = {10.1093/jac/dkaf199}
}
Kostenlos starten →